Literature DB >> 6801765

Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain.

J Sims, T H Rabbitts, P Estess, C Slaughter, P W Tucker, J D Capra.   

Abstract

The size of the gene pool potentially encoding antibodies to p-azophenyl arsonate has been examined. A heavy chain-specific full-length complementary DNA clone has been constructed with the use of messenger RNA from a hybridoma that produces antibodies to the arsonate hapten and bears nearly a full complement of the determinants comprising the cross-reactive idiotype (CRI). The sequences of both the complementary DNA clone and the corresponding immunoglobulin heavy chain have been independently determined. A probe for the variable region gene was prepared from the original heavy chain complementary DNA clone and used to analyze, by Southern filter hybridization, genomic DNA from both A/J (CRI positive) and BALB/c (CRI negative) mice. Approximately 20 to 25 restriction fragments containing "germline" variable region gene segments were detected in both strains, and many are shared by both, Since 35 CRI-positive heavy chains have been partially sequenced thus far and 31 are different, the results of the hybridization analysis suggest that somatic mutation events involving the variable region gene segments of the heavy chain play a role in the origin of the amino acid sequence diversity seen in this system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801765     DOI: 10.1126/science.6801765

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

1.  High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system.

Authors:  C A Hasemann; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  V kappa and J kappa gene segments of A/J Ars-A antibodies: somatic recombination generates the essential arginine at the junction of the variable and joining regions.

Authors:  I Sanz; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  High-frequency expression of a conserved kappa light-chain variable-region gene in chronic lymphocytic leukemia.

Authors:  T J Kipps; S Fong; E Tomhave; P P Chen; R D Goldfien; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Complete amino acid sequence of heavy chain variable regions derived from two monoclonal anti-p-azophenylarsonate antibodies of BALB/c mice expressing the major cross-reactive idiotype of the A/J strain.

Authors:  K Meek; D Jeske; M Slaoui; O Leo; J Urbain; J D Capra
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

5.  Organization of the murine immunoglobulin VH complex in the inbred strains.

Authors:  G A Rathbun; J D Capra; P W Tucker
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

6.  The generative grammar of the immune system.

Authors:  N K Jerne
Journal:  EMBO J       Date:  1985-04       Impact factor: 11.598

7.  Analysis of the distribution of charged residues in the N-terminal region of signal sequences: implications for protein export in prokaryotic and eukaryotic cells.

Authors:  G von Heijne
Journal:  EMBO J       Date:  1984-10       Impact factor: 11.598

8.  A V region determinant (idiotope) expressed at high frequency in B lymphocytes is encoded by a large set of antibody structural genes.

Authors:  R Dildrop; J Bovens; M Siekevitz; K Beyreuther; K Rajewsky
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

9.  Comparison of the hinge-coding segments in human immunoglobulin gamma heavy chain genes and the linkage of the gamma 2 and gamma 4 subclass genes.

Authors:  U Krawinkel; T H Rabbitts
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Large-scale inference of the point mutational spectrum in human segmental duplications.

Authors:  Sigve Nakken; Einar A Rødland; Torbjørn Rognes; Eivind Hovig
Journal:  BMC Genomics       Date:  2009-01-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.